Thanks to a $1.5 million grant, Columbia University Medical Center is slated to take a new specialized approach to treat pediatric cancer.

Through the Sohn Precision Medicine Program, which the center unveiled Thursday, the hospital will now provide high-risk pediatric patients with access to technology that will allow doctors to decipher the genetic code in a patient's cancer cells, according to the center.

"Today's announcement to unveil a program that's being funded by this Sohn [sic] Foundation, which allows any child from New York City with high risk cancer to access some advanced testing that we're doing here at Columbia focused on identifying the changes in genes that resulted in the development of the cancer and potentially be able to match treatments to those changes," said Dr. Andrew Kung, the director of Pediatric Oncology at the hospital.

Officials said patients across the five boroughs will be able to access the program.